Interstitial pneumonia represents the most common cause of hospitalization for coronavirus
disease 2019 (COVID-19) and may be complicated by acute distress respiratory syndrome …

Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a
reduction in lung compliance and capacity. The development of PF is relatively rare, but it …

Abstract Background Thousands of Coronavirus Disease 2019 (COVID-19) patients have
been discharged from hospitals Persistent follow-up studies are required to evaluate the …

Background Few is known about the long-term pulmonary sequelae after COVID-19
infection. Hence, the aim of this study is to characterize patients with persisting pulmonary …

Although pulmonary fibrosis can occur in the absence of a clear‐cut inciting agent, and
without a clinically clear initial acute inflammatory phase, it is more commonly associated …

It has been recently hypothesized that infection by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) may lead to fibrotic sequelae in patients recovering from …

In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …

Clinical characteristics and outcomes of post-COVID-19 pulmo... : Medicine Clinical
characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study …

Background Progressive fibrotic lung disease is one of the possible consequences of
COVID-19 pulmonary pneumonia, and it is one of the most worrying long-term …

Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …